ÀÇÎѵ¼º½

NYU Langone and Winthrop begin discussions to create an integrated healthcare network.

NYU Lutheran is determined to stop prostate cancer through clinical and technologic advances.

New technology reads DNA code with enough accuracy to reveal how bacteria defeat antibiotics.

An experimental drug prevented learning deficits caused by general anesthesia in a research model.

The study aims to render cancer cells less able to survive in low-oxygen environments.

NYU Langone study finds mother-to-child hepatitis B transmission rates reduced with tenofovir.

Erich Anderer, MD, and David Gordon, MD, join NYU Lutheran’s neurosurgery team.

The study looks at the effect modern practices during a baby’s first year have on long-term health.

Study opens door to future biologic therapies.

A new technique identifies the relationship between fatty acids and breast cancer.